Back to Janus Henderson Group Ltd. Janus Henderson Group Ltd.

CPRXCPRX
20 quarters

Position history for Janus Henderson Group Ltd.Janus Henderson Group Ltd.'s holdings in CATALYST PHARMACEUTICALS INC

Janus Henderson Group Ltd. holds 2M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $49.5M as of 2026-Q1. The position was increased (+16.2% shares). CPRX represents 0.0% of Janus Henderson Group Ltd.'s portfolio.

Current Value

$49.5M

Current Shares

2M

Total Value Change

+$48.5M

Total Shares Change

+1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2M
+16.2%
$49.5M0.0%$23.92
34
2025-Q4
Increased
1.7M
+200.6%
$40.1M0.0%$23.29
47
2025-Q3
Decreased
572,202
-23.9%
$11.3M0.0%$19.55
0
2025-Q2
Increased
751,562
+135.0%
$16.3M0.0%$21.78
45
2025-Q1
Decreased
319,829
-32.8%
$7.9M0.0%$24.69
0
2024-Q4
Increased
476,023
+32.2%
$9.9M0.0%$21.07
35
2024-Q3
Decreased
360,191
-83.4%
$7.2M0.0%$19.56
0
2024-Q2
Decreased
2.2M
-20.2%
$33.7M0.0%$15.49
0
2024-Q1
Increased
2.7M
+139.4%
$43.4M0.0%$15.94
47
2023-Q4
Increased
1.1M
+179.1%
$19.1M0.0%$16.81
46
2023-Q3
Increased
407,899
+33.1%
$4.8M0.0%$11.69
34
2023-Q2
Increased
306,507
+606.4%
$4.1M0.0%$13.53
43
2023-Q1
Increased
43,391
+116.8%
$719,6370.0%$16.46
40
2022-Q4
Decreased
20,016
-50.0%
$372,2000.0%$18.60
0
2022-Q3
Decreased
40,034
-36.9%
$514,0000.0%$12.70
0
2022-Q2
Decreased
63,464
-48.7%
$445,0000.0%$6.95
0
2022-Q1
Decreased
123,820
-21.4%
$1M0.0%$8.28
0
2021-Q4
Increased
157,547
+9.9%
$1.1M0.0%$6.89
28
2021-Q3
Decreased
143,288
-15.7%
$759,0000.0%$5.02
0
2021-Q2
New
170,063
-
$978,0000.0%$5.78
35

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used